Difficulty: Medium
Average Score: 92%
Testbank
A client is receiving morphine sulfate intravenously (IV) every 4 hours as needed for the relief of pain related to a surgical procedure the client had 3 days previously. The physician is discontinuing the IV and will be starting the client on oral pain medication. What would provide the client with optimal pain relief when discontinuing the IV dose?
Correct answer
B
Rationale
Administering an equianalgesic dose will provide the client with optimal pain relief when transitioning from IV morphine to oral medication. This approach ensures that the client receives an equivalent amount of pain relief through the oral route, accounting for differences in bioavailability and absorption between the two administration methods.
A: Administer a lower dose so the client does not get addicted to the medication. Reducing the dose may lead to inadequate pain control, which is not appropriate for a client still requiring pain management post-surgery.
C: The client should be prescribed the medication to be administered intramuscularly (IM) instead of by mouth. IM administration would not provide the desired oral transition and could result in variable absorption and delayed onset of pain relief.
D: Administer a higher dose of the medication by mouth. Increasing the dose may lead to excessive sedation or adverse effects without ensuring effective pain management, particularly given the oral bioavailability differences.
A: Administer a lower dose so the client does not get addicted to the medication. Reducing the dose may lead to inadequate pain control, which is not appropriate for a client still requiring pain management post-surgery.
C: The client should be prescribed the medication to be administered intramuscularly (IM) instead of by mouth. IM administration would not provide the desired oral transition and could result in variable absorption and delayed onset of pain relief.
D: Administer a higher dose of the medication by mouth. Increasing the dose may lead to excessive sedation or adverse effects without ensuring effective pain management, particularly given the oral bioavailability differences.